Гинекология (Jul 2023)

National medical eligibility criteria for contraceptive use 2023: focus on women's reproductive health: A review

  • Elena N. Andreeva,
  • Ekaterina V. Sheremetyeva,
  • Vera N. Prilepskaya

DOI
https://doi.org/10.26442/20795696.2023.2.202236
Journal volume & issue
Vol. 25, no. 2
pp. 124 – 132

Abstract

Read online

Reproductive health care involves helping families in this area with the provision of the necessary information. This is recognized as a key step in improving the health of men, women and children and is a fundamental human right. Everyone has the right to have access to a correct understanding of reproductive health care, choice of contraceptive method and the opportunity to benefit from scientific progress in this area. Over the past 35 years, significant progress has been made in the development of new contraceptives: the content of hormones in combined oral contraceptives has significantly decreased, inert intrauterine contraceptives have been replaced by more progressive, levonorgestrel-containing ones including low-dose generation. Combined hormonal compounds were synthesized in the form of injections, patches and vaginal rings, progestogen implantable and injectable contraceptives. Women who use contraceptives must take into account the state of health (including the presence of endocrine pathology) in order to use them without harm to their health. Based on the World Health Organization Medical Eligibility Criteria for Contraceptive Methods 2015, the Russian Medical Eligibility Criteria for Contraceptive Methods 2023 is designed to become an important tool in daily practice of doctors.

Keywords